Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients

INTRODUCTION: PREDICT is a prognostication tool that calculates the potential benefit of various postsurgical treatments on the overall survival (OS) of patients with nonmetastatic invasive breast cancer. Once patient, tumor, and treatment details have been entered, the tool will show the estimated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Zaguirre, Karen, Kai, Masaya, Kubo, Makoto, Yamada, Mai, Kurata, Kanako, Kawaji, Hitomi, Kaneshiro, Kazuhisa, Harada, Yurina, Hayashi, Saori, Shimazaki, Akiko, Morisaki, Takafumi, Mori, Hitomi, Oda, Yoshinao, Chen, Sanmei, Moriyama, Taiki, Shimizu, Shuji, Nakamura, Masafumi
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2021
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7940221/
https://ncbi.nlm.nih.gov/pubmed/33452761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3713
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items